Group A streptococcal pharyngitis and immune-mediated complications: From diagnosis to management

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 2, 2010, Pages 137-150

  Shulman, Stanford T ^a   Tanz, Robert R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

glomerulonephritis; immune mediated; pharyngitis; post streptococcal reactive arthritis; rheumatic fever; streptococcus

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFADROXIL; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEPHALOSPORIN DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HALOPERIDOL; MACROLIDE; PENICILLIN G; PHENOBARBITAL; PREDNISONE; RISPERIDONE; SALICYLIC ACID DERIVATIVE;

ACUTE GLOMERULONEPHRITIS; ANTIGEN DETECTION; BACTERIAL VIRULENCE; BLOOD ANALYSIS; CARDITIS; CHOREA MINOR; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE REDUCTION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; NONHUMAN; POLYARTHRITIS; PROGNOSIS; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC FEVER; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STREPTOCOCCAL PHARYNGITIS; SUBCUTANEOUS NODULE; SUPPURATION; THROAT CULTURE; TINEA CRURIS; ADOLESCENT; CHILD; MICROBIOLOGY; PHARYNGITIS; PRESCHOOL CHILD; SCARLET FEVER; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; PHARYNGITIS; RHEUMATIC FEVER; SCARLET FEVER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 77954476529     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.09.134     Document Type: Review

References (99)

1. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3, 191-200 (2003).
2. Tanz RR, Shulman ST. Sore throat. In: Practical Strategies in Pediatric Diagnosis and Therapy (2nd Edition). Kliegman RM, Greenbaum LA, Lye PS (Eds). Elsevier, PA, USA (2004).
3. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin. Micro. Rev. 13, 470-511 (2000).
4. Federle MJ, McIver KS, Scott JR. A response regulator that represses transcription of several virulence operons in the group A streptococcus. J. Bacteriol. 181, 3649-3657 (1999).
5. Breese BB, Hall CB. Beta Hemolytic Streptococcal Diseases. Houghton Mifflin, MA, USA (1978).
6. Haukness HA, Tanz RR, Thomson RB Jr et al. The heterogeneity of endemic community pediatric group A streptococcal pharyngeal isolates and their relationship to invasive isolates. J. Infect. Dis. 185, 915-920 (2002).
7. Stillerman M, Bernstein SH. Streptococcal pharyngitis: Evaluation of clinical syndromes in diagnosis. Am. J. Dis. Child. 101, 476-489 (1961).
8. Siegel AC, Johnson EI, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population: 1. Factors related to the attack rate of rheumatic fever. N. Engl. J. Med. 265, 559-566 (1961).
9. Levin RM, Grossman M, Jordan C, Ticknor W, Barnett P, Pascoe D. Group A streptococcal infection in children younger than three years of age. Pediatr. Infect. Dis. J. 7, 581-587 (1988).
10. Moffett HL, Cramblett HG, Smith A. Group A streptococcal infections in a children's home: II. Clinical and epidemiologic patterns of illness. Pediatrics 33, 11-17 (1964).
11. Breese BB, Disney FA. The accuracy of diagnosis of b streptococcal infections on clinical grounds. J. Pediatr. 44, 670-673 (1954).
12. McCarty M. Theories of pathogenesis of streptococcal complications. In: Streptococci and Streptococcal Disease. Wannamaker LW, Matsen JM (Eds.). Academic Press, NY, USA, 517-526 (1972).
13. Smith TD, Wilkinson V, Kaplan EL. Group A streptococcus-associated upper respiratory tract infections in a day-care center. Pediatrics 83, 380-384 (1989).
14. Alpert JJ, Pickering MR, Warren RJ. Failure to isolate streptococci from children under the age of 3 years with exudative tonsillitis. Pediatrics 38, 663-666 (1966).
15. Schwartz RH, Hayden GF, Wientzen R. Children less than three-years-old with pharyngitis: Are group A streptococci really that uncommon? Clin. Pediatr. 25, 185-188 (1986).
16. Powers GF, Boisvert PL. Age as a factor in streptococcosis. J. Pediatr. 25, 481-504 (1944).
17. Boisvert PL, Darrow DC, Powers GF, Trask JD. Streptococcosis in children: A nosographic and statistical study. Am. J. Dis. Child. 64, 516-534 (1942).
18. Bearg PA, Boisvert PL, Darrow DC, Powers GF, Trask JD. "Streptococcosis" and "streptococcic fever." Am. J. Dis. Child. 62, 431-436 (1941).
19. Segal N, El-Saied S, Puterman M. Peritonsillar abscess in children in the southern district of Israel. Int. J. Pediatr. Otorhinolaryngol. 73, 1148-1150 (2009).
20. Sunnergren O, Swanberg J, Mölstad S. Incidence, microbiology and clinical history of peritonsillar abscesses. Scand. J. Infect. Dis. 40, 752-755 (2008).
21. Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physician's probability estimates for patients with sore throats. JAMA 254, 925-929 (1985).
22. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med. Decis. Making 1, 239-246 (1981).
23. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ 158, 75-83 (1998).
24. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. CMAJ 163, 811-815 (2000).
25. McIsaac WJ, Kellmer JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA 291, 1587-1595 (2004).
26. Tanz RR, Gerber MA, Kabat W, Rippe J, Seshadri R, Shulman ST. Performance of a rapid antigen detection test and throat culture in community pediatric offices: Implications for management of pharyngitis. Pediatrics 123, 437-444 (2009).
27. Gerber MA, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin. Microbiol. Rev. 17, 571-580 (2004).
28. American Academy of Pediatrics. Group A streptococcal infections. In: Red Book: 2009 Report of the Committee on Infectious Diseases (28th Edition). Pickering LK (Ed.). American Academy of Pediatrics, IL, USA, 619-621 (2009).
29. Bisno AL, Gerber MA, Gwaltney JM Jr et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin. Infect. Dis. 35, 113-125 (2002).
30. Gerber MA, Baltimore RS, Eaton CB et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 119, 1541-1551 (2009).
31. Brien JH, Bass JW. Streptococcal pharyngitis: Optimal site for throat culture. J. Pediatr. 106, 781-783 (1985).
32. Tanz RR, Gerber MA, Shulman ST. What is a throat culture? Adv. Exp. Med. Biol. 418, 29-33 (1997).
33. Gerber MA. Diagnosis of pharyngitis: Methodology of throat culture. In: Pharyngitis: Management in an Era of Declining Rheumatic Fever. Shulman ST, (Ed.). Praeger, NY, USA, 61-71, 123-127 (1984).
34. Kaplan EL, Top EH, Dudding BA, Wannamaker LW. Diagnosis of streptococcal pharyngitis: Differentiation of active infection from the carrier state in symptomatic children. J. Infect. Dis. 123, 490-501 (1971).
35. Kaplan EL, Couser R, Huwe BB, McKay BB, Wannamaker LW. Significance of quantitative salivary cultures for group A and non-group A b-hemolytic streptococci in patients with pharyngitis and their family contacts. Pediatrics 64, 904-912 (1979).
36. Heiter BJ, Bourbeau PP. Comparison of the Gen-Probe group A streptococcus direct test with culture and a rapid streptococcal antigen detection assay for diagnosis of streptococcal pharyngitis. J. Clin. Microbiol. 31, 2070-2073 (1993).
37. Chapin KC, Blake P, Wilson CD. Performance characteristics and utilization of rapid antigen test, DNA probe, and culture detection of group A streptococci in an acute care clinic. J. Clin. Microbiol. 40, 4207-4210 (2002).
38. Uhl JR, Adamson SC, Vetter EA et al. Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J. Clin. Microbiol. 41, 242-249 (2003).
39. Gerber MA, Randolph MF, Chanatry J, Wright LL, DeMeo KK, Anderson LR. Antigen detection test for streptococcal pharyngitis: Evaluation of sensitivity with respect to true infections. J. Pediatr. 108, 654-658 (1986).
40. Edmonson MB, Farwell KR. Relationship between the clinical likelihood of group A streptococcal pharyngitis and the sensitivity of a rapid antigen-detection test in a pediatric practice. Pediatrics 115, 280-285 (2005).
41. Kurtz B, Kurtz M, Roe M, Todd J. Importance of inoculum size and sampling effect in rapid antigen detection for diagnosis of Streptococcus pyogenes pharyngitis. J. Clin. Microbiol. 38, 279-281 (2000).
42. Hall MC, Kieke B, Gonzales R et al. Spectrum bias of a rapid antigen detection test for group A b-hemolytic streptococcal pharyngitis in a pediatric population. Pediatrics 114, 182-186 (2004).
43. Gieseker KE, Roe MH, MacKenzie T, Todd JK. Evaluating the American Academy of Pediatrics diagnostic standard for Streptococcus pyogenes pharyngitis: Backup culture versus repeat rapid antigen testing. Pediatrics 111, e666 (2003).
44. DiMatteo LA, Lowenstein SR, Brimhall B, Requam W, Gonzales R. The relationship between the clinical features of pharyngitis and the sensitivity of a rapid antigen test: Evidence of spectrum bias. Ann. Emerg. Med. 38, 648-652 (2001).
45. Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann. Intern. Med. 137, 598-602 (2002).
46. Goehring C, Perrier A, Morabia A. Spectrum bias: A quantitative and graphical analysis of the variability of medical diagnostic test performance. Stat. Med. 23, 125-135 (2004).
47. Park SY, Gerber MA, Tanz RR et al. Clinicians' management of children and adolescents with acute pharyngitis. Pediatrics 117, 1871-1878 (2006).
48. Catanzaro FJ, Stetson CA, Morris LJ et al. Symposium on rheumatic fever and rheumatic heart disease: The role of the streptococcus in the pathogenesis of rheumatic fever. Am. J. Med. 17, 749-756 (1954).
49. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 253, 271-1274 (1985).
50. Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J. Pediatr. 106, 870-875 (1985).
51. Macris MH, Hartman N, Mussray B et al. Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr. Infect. Dis. J. 17, 377-381 (1998).
52. Gerber MA, Tanz RR, Kabat W et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 104, 911-917 (1999).
53. Shvartzman P, Tabenkin H, Rosentzwaig A, Dolginov F. Treatment of streptococcal pharyngitis with amoxycillin once a day. Br. Med. J. 306, 1170-1172 (1993).
54. Feder HM Jr, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL. Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics 103, 47-51 (1999).
55. Lennon DR, Farrell, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A b-haemolytic streptococcal pharyngitis. Arch. Dis. Child 93, 474-478 (2008).
56. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillin in the treatment of group A b-hemolytic streptococcal pharyngitis: A meta-analysis supporting the concept of microbial copathogenicity. Pediatr. Infect. Dis. J. 10, 275-281 (1991).
57. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: The case for penicillin therapy. Pediatr. lnfect. Dis. J. 13, 1-7 (1994).
58. Gerber MA, Tanz RR, Kabat W et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 104, 911-917 (1999).
59. Tanz RR. Convenient schedules and short course treatment of acute streptococcal pharyngitis. Pediatr. Infect. Dis. J. 19, 569-570 (2000).
60. Gerber MA, Tanz RR. New approaches to the treatment of group A streptococcal pharyngitis. Curr. Opin. Pediatr. 13, 51-55 (2001).
61. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendations for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 115, 1048-1057 (2005).
62. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34, 482-492 (2002).
63. Doktor SZ, Shortridge D. Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/lincosamide resistance. Antimicrob. Agents Chemother. 49, 3070-3072 (2005).
64. Seppälä H, Klaukka T, Lehtonen R, Nenonen R. The Finnish Study Group for Antimicrobial Resistance, Huovinen P. Outpatient use of erythromycin: Link to increased erythromycin resistance in group A streptococci. Clin. Infect. Dis. 21, 1378-1385 (1995).
65. Seppälä H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 377, 441-446 (1997).
66. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13, 1075-1078 (1994). (Pubitemid 24376761)
67. Cižman M, Pokorn M, Seme K, Orazem A, Paragi M. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother. 47, 475-477 (2001).
68. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N. Engl. J. Med. 346, 1200-1206 (2002).
69. Tanz RR, Shulman ST, Shortridge VD et al. US community-based surveillance of macrolide-resistant pharyngeal group A streptococci during three respiratory disease seasons. Clin. Infect. Dis. 39, 1794-1801 (2004).
70. Tanz RR, Tanz RJ, Rippe J et al. National and local variations in group A streptococcal macrolide resistance in North America over 7 years. Presented at: Pediatric Academic Societies' Annual Meeting. Honolulu, HI, USA, 6 May 2008.
71. Shulman ST, Tanz RR, Dale JB et al. Seven-year surveillance of North American pediatric group A streptococcal pharyngitis isolates. Clin. Infect. Dis. 49, 78-84 (2009).
72. Schwartz B, Fries S, Fitzgibbon AM, Lipman H. Pediatricians' diagnostic approach to pharyngitis and impact of CLIA 1988 on office diagnostic tests. JAMA 271, 234-238 (1994).
73. Hofer C, Binns HJ, Tanz RR. Strategies for managing group A streptococcal pharyngitis: A survey of board-certified pediatricians. Arch. Pediatr. Adolesc. Med. 151, 824-829 (1997).
74. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278(11), 901-904 (1997).
75. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin. Infect. Dis. 33(6), 757-762 (2001).
76. Weber JT. Appropriate use of antimicrobial drugs: A better prescription is needed. JAMA 294(18), 2354-2356 (2005).
77. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA 294, 2315-2322 (2005).
78. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287, 3096-3102 (2002).
79. Mangione-Smith R, Elliott MN, Wong L, McDonald L, Roski J. Measuring the quality of care for group A streptococcal pharyngitis in 5 US health plans. Arch. Pediatr. Adolesc. Med. 159, 491-497 (2005).
80. Linder JA, Chan JC, Bates DW. Evaluation and treatment of pharyngitis in primary care practice: The difference between guidelines is largely academic. Arch. Intern. Med. 166, 1374-1379 (2006).
81. Ehrlich JE, Demopoulos BP, Daniel KR Jr, Ricarte MC, Glied S. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group A streptococcal pharyngitis in a pediatric population. Prevent. Med. 35, 250-257 (2002).
82. Centor RM, Cohen SJ. Pharyngitis management: Focusing on where we agree. Arch. Intern. Med. 166, 1345-1346 (2006).
83. Webb K. Does culture confirmation of high-sensitivity rapid streptococcal tests make sense? A medical decision analysis. Pediatrics 101, E2 (1999).
84. Van Howe RS, Kusnier LP. Diagnosis and management of pharyngitis in a pediatric population based on cost-effectiveness and projected health outcomes. Pediatrics 117, 609-619 (2006).
85. Neuner JM, Hamel MB, Phillips RS, Aronson MD. Diagnosis and management of adults with pharyngitis: A cost-effectiveness analysis. Ann. Intern. Med. 139, 113-122 (2003).
86. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685-694 (2005).
87. Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: Implications in rheumatic heart disease. J. Clin. Invest. 106, 217-224 (2000).
88. Gordis L. The virtual disappearance of rheumatic fever in the US. Circulation 72, 1155-1162 (1985).
89. Shuman ST, Stollerman G, Beall B, Dale JB, Tanz RR. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin. Infect. Dis. 42, 441-447 (2006).
90. Denny F, Wannamaker L, Brink WR et al. Prevention of rheumatic fever: Treatment of the preceding streptococci infection. JAMA 143, 151-153 (1950).
91. Dajani AS, Ayoub EM, Bierman FZ et al. Guidelines for the diagnosis of rheumatic fever, 1992 update. JAMA 268, 2069-2073 (1992).
92. Marijon E, Ou P, Celermajer DS et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357, 470-476 (2007).
93. Kaplan EL, Rothermal CD, Johnson DR. ASO and anti-DNAse B titers: Normal values for children ages 2-12 in the US. Pediatrics. 101, 86-88 (1998).
94. Tompkins DG, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular IM benzathine penicillin. Circulation 45, 543 (1972).
95. Ayoub EM, Majeeb HA. Post-streptococcal reactive arthritis. Curr. Opin. Rheumatol. 12, 306-310 (2000).
96. Mackie SL, Keat A. Post-streptococcal reactive arthritis. Rheumatology 43, 949-954 (2004).
97. Ahmed S. Ayoub EM, Scornik JC. Post-streptococcal reactive arthritis. Arthritis Rheum. 41, 1096-1102 (1998).
98. Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr. Prob. Pediat. 27, 90-101 (1997).
99. Simckes AM, Spitzer A. Poststreptococcal acute glomerulonephritis. Pediat. Rev. 16, 278-279 (1995).